Literature DB >> 20809249

Fractionated radiotherapy for intracranial meningiomas.

Vinai Gondi1, Wolfgang A Tome, Minesh P Mehta.   

Abstract

Fractionated external beam radiotherapy (EBRT) has multiple roles in the management of intracranial meningiomas. In multiple series post-operative EBRT has shown improved progression-free survival following subtotal resection and a reduction in long-term failures following an apparent gross total resection. In the definitive setting, the use of EBRT has increased as the growing utilization of neuro-imaging for various conditions identifies skull-based lesions which are not easily resectable. Optic nerve sheath meningiomas represent a classic example of the use of definitive EBRT, given the frequent visual sequelae of surgery or observation. EBRT planning is highly individualized and requires a detailed understanding of tumor grade, adjacent radiosensitive structures such as the anterior optic apparatus, and radiographic characteristics of the tumor such as hyperostosis.

Entities:  

Mesh:

Year:  2010        PMID: 20809249     DOI: 10.1007/s11060-010-0368-5

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  74 in total

Review 1.  Secondary intracranial meningiomas after high-dose cranial irradiation: report of five cases and review of the literature.

Authors:  P Strojan; M Popović; B Jereb
Journal:  Int J Radiat Oncol Biol Phys       Date:  2000-08-01       Impact factor: 7.038

2.  Dose fractionation in stereotactic radiotherapy for parasellar meningiomas: radiobiological considerations of efficacy and optic nerve tolerance.

Authors:  Dennis C Shrieve; Lisa Hazard; Kenneth Boucher; Randy L Jensen
Journal:  J Neurosurg       Date:  2004-11       Impact factor: 5.115

3.  Management of atypical and malignant meningiomas: role of high-dose, 3D-conformal radiation therapy.

Authors:  E B Hug; A Devries; A F Thornton; J E Munzenride; F S Pardo; E T Hedley-Whyte; M R Bussiere; R Ojemann
Journal:  J Neurooncol       Date:  2000-06       Impact factor: 4.130

4.  Immunohistochemical analysis of p16INK4a, p14ARF, p18INK4c, p21CIP1, p27KIP1 and p73 expression in 271 meningiomas correlation with tumor grade and clinical outcome.

Authors:  Andrey Korshunov; Lyudmila Shishkina; Andrey Golanov
Journal:  Int J Cancer       Date:  2003-05-10       Impact factor: 7.396

5.  Preliminary visual outcomes after three-dimensional conformal radiation therapy for optic nerve sheath meningioma.

Authors:  Samir Narayan; Wayne T Cornblath; Howard M Sandler; Victor Elner; James A Hayman
Journal:  Int J Radiat Oncol Biol Phys       Date:  2003-06-01       Impact factor: 7.038

6.  Intracranial meningiomas: analysis of recurrence after surgical treatment.

Authors:  A Mahmood; N H Qureshi; G M Malik
Journal:  Acta Neurochir (Wien)       Date:  1994       Impact factor: 2.216

7.  Radiation therapy in the treatment of partially resected meningiomas.

Authors:  N M Barbaro; P H Gutin; C B Wilson; G E Sheline; E B Boldrey; W M Wara
Journal:  Neurosurgery       Date:  1987-04       Impact factor: 4.654

8.  Correlation of clinical and biological parameters with peritumoral edema in meningioma.

Authors:  Sun Ha Paek; Chae-Yong Kim; Young Yim Kim; In Ae Park; Min Seok Kim; Dong Gyu Kim; Hee-Won Jung
Journal:  J Neurooncol       Date:  2002-12       Impact factor: 4.130

9.  The role of radiotherapy in the treatment of subtotally resected benign meningiomas.

Authors:  R Miralbell; R M Linggood; S de la Monte; K Convery; J E Munzenrider; R O Mirimanoff
Journal:  J Neurooncol       Date:  1992-06       Impact factor: 4.130

10.  Intensity modulated radiotherapy (IMRT) for recurrent, residual, or untreated skull-base meningiomas: preliminary clinical experience.

Authors:  Andrea Pirzkall; Jürgen Debus; Peter Haering; Bernhard Rhein; Karl Heinz Grosser; Angelika Höss; M Wannenmacher
Journal:  Int J Radiat Oncol Biol Phys       Date:  2003-02-01       Impact factor: 7.038

View more
  8 in total

1.  Impaired survival and long-term neurological problems in benign meningioma.

Authors:  Hanna van Alkemade; Michelle de Leau; Edith M T Dieleman; Jan W P F Kardaun; Rob van Os; W Peter Vandertop; Wouter R van Furth; Lukas J A Stalpers
Journal:  Neuro Oncol       Date:  2012-03-09       Impact factor: 12.300

2.  Role of external beam radiotherapy in the treatment of relapsing meningioma.

Authors:  M Buglione; B De Bari; F Trevisan; P Ghirardelli; S Pedretti; L Triggiani; S M Magrini
Journal:  Med Oncol       Date:  2014-02-07       Impact factor: 3.064

Review 3.  Pediatric meningioma: current approaches and future direction.

Authors:  Rishi S Kotecha; Reimar C Junckerstorff; Sharon Lee; Catherine H Cole; Nicholas G Gottardo
Journal:  J Neurooncol       Date:  2011-01-04       Impact factor: 4.130

4.  PIK3CA mutations in meningioma.

Authors:  Gelareh Zadeh; Shirin Karimi; Kenneth D Aldape
Journal:  Neuro Oncol       Date:  2016-05       Impact factor: 12.300

Review 5.  Pediatric intracranial clear cell meningioma: a clinicopathological study of seven cases and literature review.

Authors:  Hao Li; Meng Zhao; Yuming Jiao; Zhicen Li; Ji Ma; Shuo Wang; Yong Cao; Jizong Zhao
Journal:  Childs Nerv Syst       Date:  2016-10-27       Impact factor: 1.475

6.  Recurred Intracranial Meningioma: A Retrospective Analysis for Treatment Outcome and Prognostic Factor.

Authors:  Hyun-Seung Ryu; Kyung-Sub Moon; Kyung-Hwa Lee; Woo-Youl Jang; Tae-Young Jung; In-Young Kim; Shin Jung
Journal:  Brain Tumor Res Treat       Date:  2017-11-03

Review 7.  Optic nerve sheath meningiomas: prevalence, impact, and management strategies.

Authors:  Richard T Parker; Christopher A Ovens; Clare L Fraser; Chameen Samarawickrama
Journal:  Eye Brain       Date:  2018-10-24

8.  Linac-based stereotactic radiotherapy and radiosurgery in patients with meningioma.

Authors:  David Kaul; Volker Budach; Reinhard Wurm; Arne Gruen; Lukas Graaf; Piet Habbel; Harun Badakhshi
Journal:  Radiat Oncol       Date:  2014-03-20       Impact factor: 3.481

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.